4.8 Article

PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome

Related references

Note: Only part of the references are listed.
Article Hematology

Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy

Toshiaki Yoshikawa et al.

Summary: This study identifies PRDM1 as a key epigenetic gene associated with terminal T-cell differentiation. Knockout of PRDM1 promotes early memory phenotype and polyfunctional cytokine secretion in T cells, enhancing T-cell persistence and therapeutic efficacy in multiple tumor models. Targeting PRDM1 enables the generation of superior antitumor T cells applicable to a wide range of adoptive cancer immunotherapies.

BLOOD (2022)

Article Biochemistry & Molecular Biology

In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer

Zeyu Chen et al.

Summary: Improving the effector activity of antigen-specific T cells is a major goal in cancer immunotherapy. Although several effector T cell-driving transcription factors have been identified, the transcriptional coordination of T-EFF biology remains poorly understood. This study shows that genetic deletion of Fli1 enhances T-EFF responses by restraining T-EFF lineage differentiation.
Article Biochemistry & Molecular Biology

Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade

Michael L. Dixon et al.

Summary: This study revealed the enrichment of Blimp1(+) Treg and T-FR cells in tumors, with higher tumoral T-FR signatures indicating increased risk of melanoma metastasis. Deletion of Blimp1 in Treg cells impaired suppressive activity and reprogrammed them into effector T-cells, mainly within tumor-infiltrating Treg population. This destabilization, paired with increased anti-tumor responses and reshaping of the tumor microenvironment, delayed tumor growth and improved response to anti-PD-1 blockade.

MOLECULAR CANCER (2021)

Article Immunology

Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells

Ryoji Kawakami et al.

Summary: The transcription factor Foxp3 plays crucial roles in Treg cell development and function by controlling Foxp3 transcription. Deletion of CNS0 and CNS3 completely abrogates Treg cell generation and impairs Foxp3 expression stability in residual Treg cells, leading to lethal systemic autoimmunity and inflammation. Hierarchical and coordinated activation of Foxp3 CNS0 and CNS3 initiates and stabilizes Foxp3 gene expression, crucially controlling Treg cell development and self-tolerance.

IMMUNITY (2021)

Article Biochemical Research Methods

Efficient low-cost chromatin profiling with CUT&Tag

Hatice S. Kaya-Okur et al.

NATURE PROTOCOLS (2020)

Article Medicine, Research & Experimental

Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells

Takahiro Kamiya et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Multidisciplinary Sciences

CUT&Tag for efficient epigenomic profiling of small samples and single cells

Hatice S. Kaya-Okur et al.

NATURE COMMUNICATIONS (2019)

Review Biochemistry & Molecular Biology

Mechanisms of Interplay between Transcription Factors and the 3D Genome

Seungsoo Kim et al.

MOLECULAR CELL (2019)

Article Oncology

Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma

Fabienne Desmots et al.

CLINICAL CANCER RESEARCH (2019)

Review Multidisciplinary Sciences

Developmental enhancers and chromosome topology

Eileen E. M. Furlong et al.

SCIENCE (2018)

Article Immunology

Immune Checkpoint Function of CD85j in CD8 T Cell Differentiation and Aging

Claire E. Gustafson et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Immunology

Eomesodermin promotes the development of type 1 regulatory T (TR1) cells

Ping Zhang et al.

SCIENCE IMMUNOLOGY (2017)

Article Medicine, Research & Experimental

T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression

Scott J. Patterson et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Biochemical Research Methods

Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown

Mihaela Pertea et al.

NATURE PROTOCOLS (2016)

Article Multidisciplinary Sciences

Peripheral tolerance can be modified by altering KLF2-regulated Treg migration

Sudheer K. Pabbisetty et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production

Sudheer K. Pabbisetty et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Editorial Material Immunology

Maturation of effector regulatory T cells

Naganari Ohkura et al.

NATURE IMMUNOLOGY (2011)

Review Cell Biology

An expanding job description for Blimp-1/PRDM1

Elizabeth K. Bikoff et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)

Article Multidisciplinary Sciences

The AP-1 transcription factor Batf controls TH17 differentiation

Barbara U. Schraml et al.

NATURE (2009)

Article Immunology

Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival

Gislaine A. Martins et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

Article Immunology

BLIMP1 guides the fate of effector B and T cells

Stephen L. Nutt et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Review Biochemistry & Molecular Biology

Non-MHC ligands for inhibitory immune receptors: Novel insights and implications for immune regulation

Robert Jan Lebbink et al.

MOLECULAR IMMUNOLOGY (2007)

Article Immunology

Cytokine-dependent blimp-1 expression in activated T cells inhibits IL-2 production

Dapeng Gong et al.

JOURNAL OF IMMUNOLOGY (2007)

Article Immunology

Transcriptional repressor Blimp-1 regulates T cell homeostasis and function

GA Martins et al.

NATURE IMMUNOLOGY (2006)